NHS National Framework for Transition products (Axitinib and Eltrombopag)
Details
- Buyer
- NHS England
- Published
- 4 June 2025
- Submission
- 4 July 2025
- Source
- uk:atamis:dhsc
Tender description
Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025 Offer reference number: CM/TNS/25/5722 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5722/01 Axitinib and Eltrombopag Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months) Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months) Lot 3 NWLN: 01/10/2025 to 31/01/2027 (16 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Timeline
- Completed: Tender published4 June 2025Current notice
- Completed: Submission date4 July 2025
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
Related buyers
Buyers similar to NHS England.
- 441£232.8m
- 358£99.4m
- 349£15.0bn
- 288£2.8bn
- 254£16.6bn
- 248£888.9m
- 240£507.0m
- 201£1.0bn
- 136£895.2m
- 113£59.4m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
